Cargando…
Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat
Herein, a series of 4-(benzofuran-6-yloxy)quinazoline derivatives as VEGFR-2/HDAC dual inhibitors were designed and synthesized based on fruquintinib and vorinostat. Among them, compound 13 exhibited potent inhibitory activity against VEGFR-2 and HDAC1 with IC(50) values of 57.83 nM and 9.82 nM, and...
Autores principales: | Gao, Yali, Li, Fei, Ni, Xin, Yang, Siwang, Liu, Han, Wu, Xingye, Liu, Jieqing, Ma, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523135/ https://www.ncbi.nlm.nih.gov/pubmed/37771923 http://dx.doi.org/10.1039/d3ra05542f |
Ejemplares similares
-
Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
por: Xu, Qifu, et al.
Publicado: (2020) -
The HDAC Inhibitor Vorinostat Diminishes the In Vitro Metastatic Behavior of Osteosarcoma Cells
por: Mu, Xiaodong, et al.
Publicado: (2015) -
Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal Cancer
por: Li, Qingli, et al.
Publicado: (2022) -
Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2015) -
Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization
por: Liu, Xiaojuan, et al.
Publicado: (2020)